Ono Pharmaceutical Co. Lt... (OPHLY)

AI Score

Unlock

3.95

-0.11 (-2.71%)

At close: Apr 23, 2025, 10:12 AM

Ono Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	166.14B	96.14B	69.11B	61.05B	69B	59.98B	65.27B	146.32B	110.48B
Short-Term Investments	-2.79B	68.15B	47.86B	43.93B	31.41B	11.49B	20.5B	18.38B	22.38B
Long-Term Investments	297.17B	324.18B	256B	281.39B	232.34B	267.43B	215.1B	185.14B	167.75B
Other Long-Term Assets	40.86B	n/a	1M	n/a	-3M	-1M	24.43B	21.65B	25.53B
Receivables	136.07B	114.4B	99.79B	84.27B	76.83B	76.28B	77.58B	73.25B	62.04B
Inventory	48.63B	44.81B	41.82B	39.15B	32.91B	32.82B	31.29B	25.33B	23.23B
Other Current Assets	48.06B	79.27B	59.54B	50.2B	37.77B	16.97B	20.48B	4.53B	3.05B
Total Current Assets	413.6B	345.1B	281.27B	247.64B	225.22B	194.62B	209.46B	271.03B	223.57B
Property-Plant & Equipment	104.75B	108.42B	112.13B	113.87B	114.63B	108.87B	94.32B	83.66B	80.09B
Goodwill & Intangibles	57.29B	69.13B	64.73B	70.32B	66.44B	63.06B	55.72B	45.24B	38.32B
Total Long-Term Assets	500.07B	537.34B	457.94B	499.2B	448.22B	460.44B	399.76B	346.43B	316.88B
Total Assets	913.67B	882.44B	739.2B	746.84B	673.44B	655.06B	609.23B	617.46B	540.45B
Account Payables	60.69B	66.79B	49.69B	39.16B	34.44B	36.83B	34.02B	30.91B	31.25B
Deferred Revenue	n/a	35.24B	2.24B	40.38B	41.52B	33.7B	24.19B	36.68B	11.01B
Short-Term Debt	n/a	-35.24B	-2.24B	-40.38B	-41.52B	n/a	84M	26M	38M
Other Current Liabilities	27.13B	6.68B	870M	1.77B	2.76B	2.18B	1.03B	6.15B	1.9B
Total Current Liabilities	103.62B	122.93B	65.93B	93.73B	91.33B	83.15B	68.47B	82.93B	52.19B
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.89B	1.67B	1.78B	1.87B	1.87B	3.65B	11.14B	10.32B	12B
Total Long-Term Liabilities	11.44B	11.7B	11.6B	11.95B	14.09B	9.17B	11.14B	10.32B	12B
Total Liabilities	115.06B	134.62B	77.53B	105.69B	105.42B	92.32B	79.61B	93.25B	64.19B
Total Debt	8.86B	9.17B	8.8B	9.05B	8.36B	2.2B	712M	965M	843M
Common Stock	17.36B	17.36B	17.36B	17.36B	17.36B	17.36B	17.36B	17.36B	17.36B
Retained Earnings	768.18B	709.89B	644.75B	583.36B	524.61B	499.09B	459.99B	492.24B	452.98B
Comprehensive Income	n/a	51.7B	51.24B	62.3B	48.03B	61.85B	68.02B	51.75B	43.31B
Shareholders Equity	792.96B	741.87B	655.91B	635.55B	562.48B	557.35B	524.39B	519.11B	471.39B
Total Investments	294.38B	320.86B	252.46B	278.8B	229.47B	263.26B	235.6B	203.52B	190.13B